Back to Journals » Neuropsychiatric Disease and Treatment
Neuropsychiatric Disease and Treatment
Editor-in-Chief: Dr Roger M Pinder
1176-6328 (Print) - went to online only in 2009
An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (4682)
- Volume 22, 2026 (127)
- Volume 21, 2025 (221)
- Volume 20, 2024 (228)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Latest articles:
- 5 records -
The Effect of Drug Holidays on Metacognitive and Theory of Mind Skills of Children Diagnosed with Attention Deficit Hyperactivity Disorder: Preliminary Findings
Köksal M, Sari M, İmrek Y, Öztürk Y, Özyurt G, Tufan AE
Neuropsychiatric Disease and Treatment 2026, 22:573124
Published Date: 3 July 2026
Advances in the Application of Brain–Computer Interface-Based Neurofeedback Training in the Rehabilitation of Patients with Major Depressive Disorder
Liu J, Liu L, Chen H, Xuan S, Leng X
Neuropsychiatric Disease and Treatment 2026, 22:609788
Published Date: 25 June 2026
Second-Generation Long-Acting Injectable Antipsychotics: A Comprehensive Assessment of Effectiveness, Safety, and Cost
Ifteni P, Petric PS, Popa AV, Teodorescu A, Georgescu R, Manea MC
Neuropsychiatric Disease and Treatment 2026, 22:606817
Published Date: 20 June 2026
Resting-State EEG Characteristics of Tardive Dyskinesia: Spectral and Network Connectivity Insights
Yan L, Xie B, Sun Y, Zheng M, Wang J, Li Y, Chen J, Zhou S, Yu X, Yuan J
Neuropsychiatric Disease and Treatment 2026, 22:595872
Published Date: 20 June 2026
Efficacy of Adjunctive Lumateperone 42 mg on Anhedonia and Across a Broad Range of Depressive Symptoms in Major Depressive Disorder: Post Hoc Analysis of a Phase 3, Randomized, Placebo-Controlled Trial
Thase ME, Earley WR, Kozauer SG, Chen C, Lakkis H, Durgam S
Neuropsychiatric Disease and Treatment 2026, 22:594893
Published Date: 19 June 2026